Presbyopia-Correcting Drop

WAILEA, Hawaii — At Hawaiian Eye 2021, Richard L. Lindstrom, MD, discusses his presentation on the progress being made by several companies toward pharmacological treatment of presbyopia.

The FDA acceptance of an investigational new drug application and an article diving into Demodex led recent cornea/external disease news on Healio/OSN.

New drug applications for two presbyopia-correcting drops and surgical management options have led presbyopia coverage so far this year.

The top ophthalmology stories in March included the FDA acceptance of an investigational new drug application for a presbyopia-correcting drop and a look at ophthalmology protocols during the pandemic.

Contraindications for refractive surgery and FDA news led Healio/OSN’s coverage in the beginning of March.

The FDA has accepted an investigational new drug application for Brimochol, according to a press release from Visus Therapeutics.